RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 167 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,338,000 | +61.8% | 1,184,700 | +278.6% | 0.02% | +100.0% |
Q4 2021 | $827,000 | -15.6% | 312,900 | +15.9% | 0.01% | -25.0% |
Q3 2021 | $980,000 | -49.3% | 270,000 | -39.3% | 0.01% | -53.8% |
Q2 2021 | $1,932,000 | +1023.3% | 445,000 | +790.0% | 0.03% | +550.0% |
Q1 2021 | $172,000 | – | 50,000 | +24900.0% | 0.00% | – |
Q4 2020 | $0 | -100.0% | 200 | -99.9% | 0.00% | -100.0% |
Q3 2020 | $336,000 | +166.7% | 140,000 | +154.5% | 0.01% | -20.0% |
Q4 2018 | $126,000 | – | 55,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 4,500,000 | $11,925,000 | 4.90% |
HealthInvest Partners AB | 1,090,000 | $2,889,000 | 4.07% |
GREAT POINT PARTNERS LLC | 5,000,000 | $13,250,000 | 2.94% |
CM Management, LLC | 775,000 | $2,054,000 | 1.55% |
SECTOR GAMMA AS | 1,469,604 | $3,894,000 | 0.92% |
Sio Capital Management, LLC | 913,621 | $2,421,000 | 0.73% |
Telemetry Investments, L.L.C. | 190,000 | $504,000 | 0.65% |
DAFNA Capital Management LLC | 879,000 | $2,329,000 | 0.59% |
Rock Springs Capital Management LP | 4,860,200 | $12,880,000 | 0.30% |
Rhenman & Partners Asset Management AB | 1,520,000 | $4,074,000 | 0.27% |